Say you’re on Day 6 — or 8 or 10 — of a symptomatic covid infection, and a rapid antigen test comes back positive. Could the test just be detecting bits and pieces of dead virus? If you’re a petri dish, sure. But if you’re a human, chances are you’re still infectious. Virologists weigh in.
The omicron variant upended a system in which states shared rapid covid tests with those that needed them more. Cooperation has turned into competition as states run out of supplies, limit which organizations get them, or hold on to expired kits as a last resort.
Temporary subsidies helped boost enrollment under the Affordable Care Act to a record 14.5 million, according to the Department of Health and Human Services. But unless Democrats in Congress extend those subsidies, many of those new enrollees will be in for a rude surprise just ahead of midterm elections. Meanwhile, the need to replace retiring Supreme Court Justice Stephen Breyer further crowds an already tight legislative schedule. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet, and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Diana Greene Foster, author of “The Turnaway Study: Ten Years, a Thousand Women, and the Consequences of Having — Or Being Denied — An Abortion.”
The health agency and the White House acted in the wake of a KHN story about pharmacists refusing to give shots to patients with moderate to severe immune suppression.
The Centers for Disease Control and Prevention quietly changed its guidance to allow an extra shot in certain cases, but some pharmacy personnel are confused about who is eligible.
Just 18% of 5- to 11-year-olds are fully vaccinated, with rates varying significantly across the country, a KHN analysis of federal data shows. Pediatricians say the slow pace and geographic disparities are alarming, especially against the backdrop of record numbers of cases and pediatric hospitalizations.
Medicare officials tentatively plan to restrict the use of a controversial Alzheimer’s drug to only those patients participating in clinical trials, while the Department of Health and Human Services looks into lowering the monthly Medicare Part B premium. Meanwhile, covid confusion still reigns, as the Biden administration moves, belatedly, to make more masks and tests available. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more.
More than 20 years after the terrorist attacks, the World Trade Center Health Program is considering covering the most common form of uterine cancer, in what patient advocates say is a key acknowledgment of the women affected by the 9/11 fallout.
With the omicron variant surging throughout the U.S., many experts warn that a single-layer cloth mask is not enough protection. Instead, they recommend an upgrade: layering wardrobe masks with surgical masks or wearing an N95 or KN95 respirator.
It’s 2022 and the covid-19 pandemic is still with us, as are congressional efforts to pass President Joe Biden’s big health and social spending bill. But other issues seem certain to take center stage on this year’s health agenda, including abortion, the state of the health care workforce, and prescription drug prices. Tami Luhby of CNN, Alice Miranda Ollstein of Politico and Mary Ellen McIntire of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN’s Victoria Knight, who reported the latest KHN-NPR “Bill of the Month” episode.
